MoneyWorks4Me

SMS Lifesciences India informs about disclosure

26 Mar 2024 Evaluate
SMS Lifesciences India has informed that the Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 2024 for Vamsi Krishna Potluri.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..